Complete final analysis of the ARTI-19 clinical trial
Delivered after the deadline (146 days after the deadline)
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 2 Feb 2021
- Due
- 31 Mar 2021
- Delivered
- 24 Aug 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“final analysis is expected in March 2021”
What we found
Evidence strength A What the grades mean
The company announced the results of the preplanned prospective analysis of the ARTI-19 clinical trial on August 24, 2021, which occurred after the March 2021 deadline.
-
A Mateon Therapeutics Inc. 10-Q filed 2021-11-22
“On August 24, 2021, the Company announced that PulmoHealTM and ArtiVedaTM have proven to be effective against mild and moderate COVID-19 following the preplanned prospective analysis of the Company’s ARTI-19 clinical trial.” ✓ confirmed on the page
Market reaction: the shares moved -8.5% against the S&P 500 over the three sessions around the disclosure (19 Nov 2021 to 24 Nov 2021). What this measures
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- ARTI-19 trial final analysis
- Where
- India
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Not met”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Mateon Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-OTLC-022846 · Corrections policy